Antihypertensive therapy and regression of coronary artery disease: Insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials

Publication | Closed Access

Antihypertensive therapy and regression of coronary artery disease: Insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials

DOI

Citations

References

2006

Year

Sorin J. Brener, Thomas B. Ivanc, Roman Poliszczuk, Michael Chen, E. Murat Tuzcu, Tingfei Hu, David J. Frid, Steven E. Nissen

American Heart Journal

ThrombosisHypertensionCardiovascular DiseaseStrokeAtherosclerosisMedicineAntihypertensive TherapyAmlodipine Versus EnalaprilArterial DiseasePublic HealthPharmacologyCardiologyCardiac ImagingCoronary Artery DiseaseAnesthesiologyCardiovascular Imaging